Reata Pharmaceuticals Inc (NASDAQ:RETA)

92.15
Delayed Data
As of Jun 05
 -0.87 / -0.94%
Today’s Change
18.47
Today|||52-Week Range
106.69
+142.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$3.5B

Company Description

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.

Contact Information

Reata Pharmaceuticals, Inc.
5320 Legacy Drive
Plano Texas 75024
P:(972) 865-2219
Investor Relations:

Employees

Shareholders

Other institutional51.44%
Mutual fund holders28.52%
Individual stakeholders24.59%

Top Executives

J. Warren HuffChairman & Chief Executive Officer
Manmeet Singh SoniPresident, Chief Operating & Financial Officer
W. Christian WigleyChief Scientific Officer & Senior Vice President
Samina KhanChief Medical Officer & Senior Vice President
Dakota GallivanVP, Chief Healthcare & Compliance Officer